Relx (LON:REL)‘s stock had its “buy” rating reaffirmed by research analysts at Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell in a research report issued to clients and investors on Monday, Price Targets.com reports. They currently have a GBX 2,300 ($30.05) price objective on the stock. Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell’s price objective would indicate a potential upside of 15.00% from the company’s previous close.
REL has been the topic of several other reports. Morgan Stanley reiterated a “buy” rating and set a GBX 2,100 ($27.44) price objective on shares of Relx in a research report on Wednesday, June 30th. Barclays set a GBX 2,235 ($29.20) target price on Relx in a report on Friday. JPMorgan Chase & Co. increased their target price on Relx from GBX 2,026 ($26.47) to GBX 2,050 ($26.78) and gave the company an “overweight” rating in a report on Wednesday, June 23rd. Deutsche Bank Aktiengesellschaft restated a “neutral” rating on shares of Relx in a report on Thursday, March 18th. Finally, UBS Group restated a “neutral” rating and set a GBX 1,940 ($25.35) target price on shares of Relx in a report on Monday, June 28th. Three investment analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average price target of GBX 2,115.22 ($27.64).
Shares of Relx stock traded up GBX 25.50 ($0.33) during trading on Monday, hitting GBX 2,000 ($26.13). 2,469,122 shares of the stock traded hands, compared to its average volume of 2,529,514. The company has a debt-to-equity ratio of 339.17, a quick ratio of 0.41 and a current ratio of 0.52. The company has a market capitalization of £38.67 billion and a PE ratio of 31.65. The business has a fifty day simple moving average of GBX 1,889.10. Relx has a 52 week low of GBX 1,484.90 ($19.40) and a 52 week high of GBX 2,000 ($26.13).
RELX PLC provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Scientific, Technical & Medical; Risk; Legal; and Exhibitions. The Scientific, Technical & Medical segment provides information and analytics that help institutions and professionals to progress in science and advance healthcare.
Recommended Story: What Is Dividend Yield and How Do You Calculate It?
Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.